12
articles this month.
Aghabiklooei
A, Hassanian-Moghaddam H, Zamani N, Shadnia S, Mashayekhian M, Rahimi M,
Nasouhi S, Ghoochani A.
Biomed
Res Int. 2013;2013:903172. Epub 2013 Sep 9.
Comments:
Interesting use of the long-acting opioid antagonist naltrexone in this study
from Iran. The likely downside of this approach of course is that, in those
with opioid dependence (constituting the vast majority of overdose cases), it
doesn’t allow for titration of antagonist effect to minimize withdrawal
symptoms.
Bruce
RD, Winkle P, Custodio JM, Wei X, Rhee MS, Kearney BP, Ramanathan S, Friedland
GH.
Antimicrob
Agents Chemother.2013 Sep 30. [Epub ahead of print]
Comments: This is a
promising finding for the new HIV regimen.
Schreiber
S, Barak Y, Hostovsky A, Baratz-Goldstein R, Volis I, Rubovitch V, Pick CG.
J
MolNeurosci.2013 Sep 22. [Epub ahead of print]
Comments: Really
interesting study, since many opioid overdoses occur in the presence of
anti-depressant medications. These results are too preliminary to draw strong
conclusions, but it’s an important pursuit.
Green
TC, Zaller N, Palacios WR, Bowman SE, Ray M, Heimer R, Case P.
Drug Alcohol Depend.2013 Sep 2.doi:pii:
S0376-8716(13)00334-7. 10.1016/j.drugalcdep.2013.08.018. [Epub ahead of print]
Comments:
Interesting qualitative analysis of police attitudes toward lay naloxone.
Meshesha
LZ, Tsui JI, Liebschutz JM, Crooks D, Anderson BJ, Herman DS, Stein MD.
Addict
Behav. 2013 Aug 14;38(12):2884-2887. doi:
Comments: More days
of heroin use is associated with worse self-reported health and worse
self-reported health is associated with non-fatal overdose events.
Lee
WK, Ti L, Hayashi K, Kaplan K, Suwannawong P, Wood E, Kerr T.
Subst
Abuse Treat Prev Policy. 2013 Sep 10;8(1):32. [Epub ahead of print]
Comments: This is a
useful contribution to overdose literature. There has long been a concern that
people who require assistance to inject (often women) would overdose more. This
hasn’t held up in studies and this study corroborates that lack of association.
It may be well worth exploring further, but thus far we don’t have any evidence
that assistance with injecting increases overdose risk.
[No
authors listed]
Emerg
Med J. 2013 Oct;30(10):860. doi: 10.1136/emermed-2013-203100.3.
Comments: Yes, in
breathing patients.
[No
authors listed]
Lancet.
2013 Sep 7;382(9895):833. doi: 10.1016/S0140-6736(13)61844-9. No abstract
available.
Comments: Brief
commentary on opioid overdose mortality in UK and US. Notable that there is no
mention of naloxone.
Bouab
O, Lahmek P, Meunier N, Aubin HJ, Michel L.
Rev
Med Brux. 2013 May-Jun;34(3):132-40. French.
Comments: Basically
inpatient withdrawal from agonist maintenance treatment.
Bruce
RD, Winkle P, Custodio JM, Wei LX, Rhee MS, Kearney BP, Ramanathan S, Friedland
GH.
J
Acquir Immune DeficSyndr. 2013 Aug 1;63(4):480-4. doi:
10.1097/QAI.0b013e3182961d31.
Comments: The new
combined HIV med (Stribild) modestly increases buprenorphine levels.
Arora
A, Williams K.
Acute
Med. 2013;12(1):51-4. Review.
Comments: Methadone
maintenance review.
Harris
JL, Lorvick J, Wenger L, Wilkins T, Iguchi MY, Bourgois P, Kral AH.
J
Urban Health. 2013 Apr;90(2):299-306. doi: 10.1007/s11524-012-9720-8.
Comments: Another
useful contribution – infrequent heroin injectors had a lower risk of non-fatal
overdose. As with most overdose epidemiology, the relationship between use
frequency and overdose risk is likely complex.
No comments:
Post a Comment